메뉴 건너뛰기




Volumn 34, Issue 3, 2014, Pages 519-524

Influence of axial length and postinjection reflux on sustained intraocular pressure elevation as a result of intravitreal anti-vascular endothelial growth factor therapy

Author keywords

axial; bevacizumab; injection; IOP; length; pressure; ranibizumab; reflux; sustained; transient

Indexed keywords

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; AXIAL LENGTH, EYE; HUMANS; INTRAOCULAR PRESSURE; MACULAR DEGENERATION; NEOVASCULARIZATION, PATHOLOGIC; OCULAR HYPERTENSION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84894458521     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000039     Document Type: Article
Times cited : (21)

References (29)
  • 1
    • 33749445317 scopus 로고    scopus 로고
    • Ranibizumab for neovascular age-related macular degeneration
    • MARINA Study Group
    • Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431.
    • (2006) N Engl J Med , vol.355 , pp. 1419-1431
    • Rosenfeld, P.J.1    Brown, D.M.2    Heier, J.S.3
  • 2
    • 33749451356 scopus 로고    scopus 로고
    • Ranibizumab versus verteporfin for neovascular age-related macular degeneration
    • ANCHOR Study Group
    • Brown DM, Kaiser PK,Michels M, et al; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-1444.
    • (2006) N Engl J Med , vol.355 , pp. 1432-1444
    • Brown, D.M.1    Kaiser, P.K.2    Michels, M.3
  • 3
    • 38149142388 scopus 로고    scopus 로고
    • Short-term intraocular pressure changes after intravitreal injection of bevacizumab
    • Hollands H, Wong J, Bruen R, et al. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol 2007;42:807-811.
    • (2007) Can J Ophthalmol , vol.42 , pp. 807-811
    • Hollands, H.1    Wong, J.2    Bruen, R.3
  • 4
    • 56249105395 scopus 로고    scopus 로고
    • Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents
    • Kim JE, Mantravadi AV, Hur EY, Covert DJ. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol 2008;146:930-934.
    • (2008) Am J Ophthalmol , vol.146 , pp. 930-934
    • Kim, J.E.1    Mantravadi, A.V.2    Hur, E.Y.3    Covert, D.J.4
  • 5
    • 41849146421 scopus 로고    scopus 로고
    • Short-term intraocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related macular degeneration
    • Mojica G, Hariprasad SM, Jager RD, Mieler WF. Short-term intraocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related macular degeneration. Br J Ophthalmol 2008;92:584.
    • (2008) Br J Ophthalmol , vol.92 , pp. 584
    • Mojica, G.1    Hariprasad, S.M.2    Jager, R.D.3    Mieler, W.F.4
  • 6
    • 58249105827 scopus 로고    scopus 로고
    • Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab
    • Bakri SJ, Pulido JS, McCannel CA, et al. Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye (Lond) 2009;23:181-185.
    • (2009) Eye (Lond) , vol.23 , pp. 181-185
    • Bakri, S.J.1    Pulido, J.S.2    McCannel, C.A.3
  • 7
    • 11144239923 scopus 로고    scopus 로고
    • Pegaptanib for neovascular age-related macular degeneration
    • VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group
    • Gragoudas ES, Adamis AP, Cunningham ET Jr, et al; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-2816.
    • (2004) N Engl J Med , vol.351 , pp. 2805-2816
    • Gragoudas, E.S.1    Adamis, A.P.2    Cunningham Jr., E.T.3
  • 8
    • 33646948521 scopus 로고    scopus 로고
    • Pegaptanib sodium for neovascular age-related macular degeneration: Two-year safety results of the two prospective, multicenter, controlled clinical trials
    • VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group
    • VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group, D'Amico DJ, Masonson HN, et al. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 2006;113:992-1001.
    • (2006) Ophthalmology , vol.113 , pp. 992-1001
    • D'Amico, D.J.1    Masonson, H.N.2
  • 9
    • 79960648025 scopus 로고    scopus 로고
    • Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents
    • Good TJ, Kimura AE, Mandava N, Kahook MY. Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents. Br J Ophthalmol 2011;95:1111-1114.
    • (2011) Br J Ophthalmol , vol.95 , pp. 1111-1114
    • Good, T.J.1    Kimura, A.E.2    Mandava, N.3    Kahook, M.Y.4
  • 11
    • 67149143227 scopus 로고    scopus 로고
    • Sustained elevation in intraocular pressure associated with intravitreal bevacizumab injections
    • Kahook MY, Kimura AE, Wong LJ, et al. Sustained elevation in intraocular pressure associated with intravitreal bevacizumab injections. Ophthalmic Surg Lasers Imaging 2009;40:293-295.
    • (2009) Ophthalmic Surg Lasers Imaging , vol.40 , pp. 293-295
    • Kahook, M.Y.1    Kimura, A.E.2    Wong, L.J.3
  • 12
    • 77649324295 scopus 로고    scopus 로고
    • Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections
    • Adelman RA, Zheng Q, Mayer HR. Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections. J Ocul Pharmacol Ther 2010;26:105-110.
    • (2010) J Ocul Pharmacol Ther , vol.26 , pp. 105-110
    • Adelman, R.A.1    Zheng, Q.2    Mayer, H.R.3
  • 13
    • 84859433783 scopus 로고    scopus 로고
    • Sustained increased intraocular pressure related to intravitreal anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration
    • Tseng JJ, Vance SK, Della Torre KE, et al. Sustained increased intraocular pressure related to intravitreal anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration. J Glaucoma 2012;21:241-247.
    • (2012) J Glaucoma , vol.21 , pp. 241-247
    • Tseng, J.J.1    Vance, S.K.2    Della Torre, K.E.3
  • 14
    • 79959696606 scopus 로고    scopus 로고
    • Sustained ocular hypertension following intravitreal injections of 0.5 mg/0.05 ml ranibizumab
    • Loukianou E, Brouzas D, Apostolopoulos M. Sustained ocular hypertension following intravitreal injections of 0.5 mg/0.05 ml ranibizumab. Int Ophthalmol 2011;31:211-213.
    • (2011) Int Ophthalmol , vol.31 , pp. 211-213
    • Loukianou, E.1    Brouzas, D.2    Apostolopoulos, M.3
  • 15
    • 79958260082 scopus 로고    scopus 로고
    • Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib
    • Choi D, Ortube M, McCannel C, et al. Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib. Retina 2011;31: 1028-1035.
    • (2011) Retina , vol.31 , pp. 1028-1035
    • Choi, D.1    Ortube, M.2    McCannel, C.3
  • 16
    • 84856539469 scopus 로고    scopus 로고
    • Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections
    • Hoang QV, Mendonca LS, Della Torre KE, et al. Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections. Ophthalmology 2012;119:321-326.
    • (2012) Ophthalmology , vol.119 , pp. 321-326
    • Hoang, Q.V.1    Mendonca, L.S.2    Della Torre, K.E.3
  • 17
    • 84872076788 scopus 로고    scopus 로고
    • Clinical predictors of sustained intraocular pressure elevation due to intravitreal antivascular endothelial growth factor therapy
    • Hoang QV, Tsuang AJ, Gelman R, et al. Clinical predictors of sustained intraocular pressure elevation due to intravitreal antivascular endothelial growth factor therapy. Retina 2013;33: 179-187.
    • (2013) Retina , vol.33 , pp. 179-187
    • Hoang, Q.V.1    Tsuang, A.J.2    Gelman, R.3
  • 18
    • 73349096955 scopus 로고    scopus 로고
    • Treat and extend dosing of intravitreal antivascular endothelial growth factor therapy for type 3 neovascularization/retinal angiomatous proliferation
    • Engelbert M, Zweifel SA, Freund KB. "Treat and extend" dosing of intravitreal antivascular endothelial growth factor therapy for type 3 neovascularization/retinal angiomatous proliferation. Retina 2009;29:1424-1431.
    • (2009) Retina , vol.29 , pp. 1424-1431
    • Engelbert, M.1    Zweifel, S.A.2    Freund, K.B.3
  • 20
    • 0034787949 scopus 로고    scopus 로고
    • Relationship between aqueous humor protein level and outflow facility in patients with uveitis
    • Ladas JG, Yu F, Loo R, et al. Relationship between aqueous humor protein level and outflow facility in patients with uveitis. Invest Ophthalmol Vis Sci 2001;42:2584-2588.
    • (2001) Invest Ophthalmol Vis Sci , vol.42 , pp. 2584-2588
    • Ladas, J.G.1    Yu, F.2    Loo, R.3
  • 21
    • 64849085452 scopus 로고    scopus 로고
    • Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin)
    • Georgopoulos M, Polak K, Prager F, et al. Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin). Br J Ophthalmol 2009;93:457-462.
    • (2009) Br J Ophthalmol , vol.93 , pp. 457-462
    • Georgopoulos, M.1    Polak, K.2    Prager, F.3
  • 22
    • 36549035398 scopus 로고    scopus 로고
    • Bevacizumab is not toxic to human anterior-and posterior-segment cultured cells [in German]
    • Kernt M, Welge-Lüssen U, Yu A, et al. Bevacizumab is not toxic to human anterior-and posterior-segment cultured cells [in German]. Ophthalmologe 2007;104:965-971.
    • (2007) Ophthalmologe , vol.104 , pp. 965-971
    • Kernt, M.1    Welge-Lüssen, U.2    Yu, A.3
  • 23
    • 85056030983 scopus 로고    scopus 로고
    • Sustained intraocular pressure elevation after intravitreal injection of bevacizumab and ranibizumab associated with trabeculitis
    • Sniegowski M, Mandava N, Kahook MY. Sustained intraocular pressure elevation after intravitreal injection of bevacizumab and ranibizumab associated with trabeculitis. Open Ophthalmol J 2010;4:28-29.
    • (2010) Open Ophthalmol J , vol.4 , pp. 28-29
    • Sniegowski, M.1    Mandava, N.2    Kahook, M.Y.3
  • 24
    • 79953266988 scopus 로고    scopus 로고
    • Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: Effects of long-term storage and product mishandling
    • Liu L, Ammar DA, Ross L, et al. Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling. Invest Ophthalmol Vis Sci 2011;52:1023-1034.
    • (2011) Invest Ophthalmol Vis Sci , vol.52 , pp. 1023-1034
    • Liu, L.1    Ammar, D.A.2    Ross, L.3
  • 25
    • 84867747951 scopus 로고    scopus 로고
    • Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration
    • Mathalone N, Arodi-Golan A, Sar S, et al. Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2012;250:1435-1440.
    • (2012) Graefes Arch Clin Exp Ophthalmol , vol.250 , pp. 1435-1440
    • Mathalone, N.1    Arodi-Golan, A.2    Sar, S.3
  • 26
    • 74549191872 scopus 로고    scopus 로고
    • Short-term effect of intravitreal injection of ranibizumab (Lucentis) on intraocular pressure
    • Gismondi M, Salati C, Salvetat ML, et al. Short-term effect of intravitreal injection of ranibizumab (Lucentis) on intraocular pressure. J Glaucoma 2009;18:658-661.
    • (2009) J Glaucoma , vol.18 , pp. 658-661
    • Gismondi, M.1    Salati, C.2    Salvetat, M.L.3
  • 27
    • 84874640819 scopus 로고    scopus 로고
    • Effect of dorzolamide/timolol or brinzolamide/timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension
    • Kim GN, Han YS, Chung IY, et al. Effect of dorzolamide/timolol or brinzolamide/timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension. Semin Ophthalmol 2013;28:61-67.
    • (2013) Semin Ophthalmol , vol.28 , pp. 61-67
    • Kim, G.N.1    Han, Y.S.2    Chung, I.Y.3
  • 28
    • 82955203471 scopus 로고    scopus 로고
    • Effect of the Honan intraocular pressure reducer on intraocular pressure increase following intravitreal injection using the tunneled scleral technique
    • Kim KS, Jee D. Effect of the Honan intraocular pressure reducer on intraocular pressure increase following intravitreal injection using the tunneled scleral technique. Jpn J Ophthalmol 2011;55:632-637.
    • (2011) Jpn J Ophthalmol , vol.55 , pp. 632-637
    • Kim, K.S.1    Jee, D.2
  • 29
    • 84916604489 scopus 로고    scopus 로고
    • Ocular decompression with cotton swabs lowers intraocular pressure elevation after intravitreal injection
    • Epub ahead of print
    • Gregori NZ, WeissMJ, Goldhardt R, et al. Ocular decompression with cotton swabs lowers intraocular pressure elevation after intravitreal injection. J Glaucoma 2013. Epub ahead of print.
    • J Glaucoma 2013
    • Gregori, N.Z.1    Weiss, M.J.2    Goldhardt, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.